| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.99▲ | 3.02▼ | 3.03▼ | 2.87▲ | 2.85▲ |
| MA10 | 3.01▼ | 3.01▼ | 3.15▼ | 2.72▲ | 2.48▲ |
| MA20 | 3.03▼ | 3.15▼ | 2.94▲ | 2.70▲ | 2.03▲ |
| MA50 | 3.03▼ | 2.83▲ | 2.76▲ | 2.26▲ | 2.05▲ |
| MA100 | 3.11▼ | 2.73▲ | 2.74▲ | 1.95▲ | 7.02▼ |
| MA200 | 2.97▲ | 2.72▲ | 2.58▲ | 1.87▲ | 7.08▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.034▼ | -0.021▼ | 0.023▲ | 0.205▲ |
| RSI | 43.544▼ | 48.976▼ | 52.300▲ | 56.847▲ | 58.302▲ |
| STOCH | 8.783▼ | 55.715 | 29.770 | 49.333 | 72.496 |
| WILL %R | -86.364▼ | -74.176 | -61.927 | -50.382 | -27.386 |
| CCI | -88.022 | -32.013 | -48.817 | 119.994▲ | 116.046▲ |
| ▲ PSAR&MOM | $CABA PSAR Switch Up + Momentum | Set Alert |
| ▲ RSI&MACD | $CABA MACD cross and RSI above 55 | Set Alert |
| ▲ RSI&VOL | $CABA RSI Cross Up and Volume | Set Alert |
| RSI | $CABA RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $CABA MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $CABA Price Crossed Above MA(26) | Set Alert |
| MA | $CABA Price Crossed Above MA(13) | Set Alert |
| MA | $CABA Price Crossed Above MA(7) | Set Alert |
| ▲ GAP | $CABA Open Gap Up %5 | Set Alert |
| ▲ GAP | $CABA Open Gap Up %3 | Set Alert |
| ▲ GAP | $CABA Open Gap Up %2 | Set Alert |
| ▲ BREAK | $CABA Price Breaks 60 Days High | Set Alert |
| ▲ BREAK | $CABA Price Breaks 30 Days High | Set Alert |
| ▲ BREAK | $CABA Price Breaks 20 Days High | Set Alert |
| ▲ BREAK | $CABA Price Breaks 10 Days High | Set Alert |
|
Friday, October 31, 2025 02:42 AM
Cabaletta Bio Inc. (NASDAQ:CABA) is one of the best stocks under $3 to invest in. On October 27, Cabaletta Bio announced positive clinical data and development updates for its investigational targeted ...
|
|
Monday, October 27, 2025 04:21 AM
All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS resp ...
|
|
Tuesday, October 21, 2025 08:00 AM
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced the appointment of Steve Gavel as Chief Commercial Officer, effective immediately. Gavel will oversee all aspects of commercial strategy ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/11/25 | 3.56 | 3.575 | 2.75 | 3.01 | 11,650,977 |
| 31/10/25 | 2.61 | 3.67 | 2.56 | 3.61 | 35,910,240 |
| 30/10/25 | 2.48 | 2.52 | 2.39 | 2.47 | 2,464,142 |
| 29/10/25 | 2.71 | 2.75 | 2.465 | 2.50 | 2,365,891 |
| 28/10/25 | 2.79 | 2.89 | 2.687 | 2.74 | 1,953,433 |
| 27/10/25 | 2.54 | 2.85 | 2.49 | 2.79 | 4,288,344 |
| 24/10/25 | 2.43 | 2.52 | 2.36 | 2.47 | 1,847,684 |
| 23/10/25 | 2.45 | 2.48 | 2.36 | 2.41 | 1,636,576 |
| 22/10/25 | 2.71 | 2.74 | 2.38 | 2.45 | 3,947,026 |
| 21/10/25 | 2.81 | 2.82 | 2.60 | 2.74 | 3,118,652 |
|
|
||||
|
|
||||
|
|